0002030783-24-000001.txt : 20240724 0002030783-24-000001.hdr.sgml : 20240724 20240724133720 ACCESSION NUMBER: 0002030783-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240724 DATE AS OF CHANGE: 20240724 EFFECTIVENESS DATE: 20240724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Valora Therapeutics, Inc. CENTRAL INDEX KEY: 0002030783 ORGANIZATION NAME: IRS NUMBER: 923639728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-519627 FILM NUMBER: 241137402 BUSINESS ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-205-5904 MAIL ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0002030783 Valora Therapeutics, Inc. 11099 N. TORREY PINES ROAD SUITE 290 LA JOLLA CA CALIFORNIA 92037 858-205-5904 DELAWARE None None Corporation true 2023 Miguel Garcia-Guzman 11099 N Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Sanford Madigan 11099 N Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Stefan Heller 11099 N Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2024-07-09 false true false 0 29185231 13039726 16145505 Total amount sold includes amounts paid in cash and pursuant to conversion of convertible securities. false 12 0 0 0 false Valora Therapeutics, Inc. /s/ Miguel Garcia-Guzman Miguel Garcia-Guzman Chief Executive Officer 2024-07-24